If you have questions about weight loss, your Baptist Health bariatric care provider can help
This applies to both brand-name and compounded versions
What It Targets Our Tesamorelin + Ipamorelin peptide blendis designed to target: Visceral and central abdominal fat that resists diet and exercise and is linked to cardiometabolic risk. Skinny fat or soft midsections where clients want more definition, not just scale loss. Loss of lean muscle mass, slower recovery, and reduced training capacity in busy, highoutput adults. Metabolic issues such as insulin resistance, unfavorable lipids, or agerelated abdominal obesity in clients already working on lifestyle
This is the dose where dose-escalation-related side effects became clinically significant in the trial data
in 18 rounds | Career: 70.39 stroke avg
Alternative Treatment Options While GLP-1 medications can be helpful tools, it's important to understand the potential risks and side effects associated with these drugs